Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tomasz Adam Ciach | M | 58 |
NanoSanguis SA
 NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland.
NanoThea SA
 NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | 12 years |
| Marek Borzestowski | M | 52 |
NanoThea SA
NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.
NanoSanguis SA
NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland. | - |
| Pawel Michal Ciach | M | 56 |
NanoSanguis SA
NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland.
NanoThea SA
NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | - |
| Magdalena Janczewska | F | - |
NanoThea SA
NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | 12 years |
| Agata Stefanek | F | - |
NanoSanguis SA
NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland. | 9 years |
| Piotr Wojciech Pietrzak | M | 44 |
NanoThea SA
NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | 9 years |
| Maciej Sadowski | M | - |
NanoSanguis SA
NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Poland | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kamil Kopec
- Personal Network
